Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7091261 | 0.86 | SIGMAR1 (0.50) | MEN1LMNATHRBBLMKMT2A | |
| Bromide SCHEMBL9225776 | 0.83 | ABCB1 (0.46) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL8406799 | 0.83 | ERN1 (0.48) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL872046 | 0.83 | LMNA (0.52) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL31588310 | 0.83 | LMNA (0.52) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL10685282 | 0.81 | HTR1A (0.49) | TDP1HTR1ADRD2ALDH1A1HTT | |
| SCHEMBL9721777 | 0.79 | KCNH2 (0.46) | ALDH1A1HPGDHTR2AHSD17B10SIGMAR1 | |
| SCHEMBL5073359 | 0.79 | MAPT (0.45) | TDP1HTR1ADRD2NR1H2NR1H3 | |
| SCHEMBL14465961 | 0.78 | LMNA (0.52) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL9101479 | 0.78 | HSD17B3 (0.48) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141855-A1 | PROTEIN CONJUGATES WITH MULTIPLE PAYLOADS AND METHODS FOR MAKING THE SAME | GLYCO-THERAPY BIOTECHNOLOGY CO., LTD. (CN) | 2023-08-03 | — | — | WO | disclosed |
| US-20210300872-A1 | SECOND GENERATION GRP94-SELECTIVE INHIBITORS | UNIVERSITY OF KANSAS | 2021-09-30 | — | — | US | disclosed |
| US-20200190017-A1 | SECOND GENERATION GRP94-SELECTIVE INHIBITORS | UNIVERSITY OF KANSAS | 2020-06-18 | — | — | US | disclosed |
| US-8343961-B2 | Substituted heterocyclic compounds | ARQULE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| EP-2414361-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | ArQule, Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010114894-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | ARQULE, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| US-20100249115-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | ARQULE, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| CN-100360580-C | Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds | AVENTIS PHARM PROD INC (US) | 2008-01-09 | — | — | CN | disclosed |
| CN-1769318-A | Polymeric resin compounds and their preparation | AVENTIS PHARM PROD INC (US) | 2006-05-10 | — | — | CN | disclosed |
| US-4994539-A | Ethylene-unsaturated aromatic copolymer | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1991-02-19 | — | — | US | disclosed |
| EP-0180771-B1 | METHOD FOR IMPROVING IMPULSE BREAKDOWN STRENGTH OF ELECTRICALLY INSULATING MATERIALS | Nippon Petrochemicals Co., Ltd. (JP) | 1989-08-02 | — | — | EP | disclosed |
| EP-0114385-B1 | ELECTRICAL INSULATING OIL AND OIL-FILLED ELECTRICAL APPLIANCES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1987-08-05 | — | — | EP | disclosed |
| EP-0227487-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
| EP-0103868-B1 | IMPROVED ELECTRICAL INSULATING OIL AND OIL-FILLED ELECTRICAL APPLIANCES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1987-04-08 | — | — | EP | disclosed |
| EP-0180771-A1 | Method for improving impulse breakdown strength of electrically insulating materials | Nippon Petrochemicals Co., Ltd. (JP) | 1986-05-14 | — | — | EP | disclosed |
| US-4543207-A | ORGANIC ACID ESTERS, AROMATIC ETHERS, ANIMAL OILS, VEGETABLE OILS,AND AROMATIC OLEFINS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-09-24 | — | — | US | disclosed |
| US-4493943-A | MIXTURES OF DIARYLALKANES AND AROMATIC MONO-OR DI-OLEFINS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-01-15 | — | — | US | disclosed |
| EP-0114385-A2 | Electrical insulating oil and oil-filled electrical appliances | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-08-01 | — | — | EP | disclosed |
| EP-0103868-A2 | Improved electrical insulating oil and oil-filled electrical appliances | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249115-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | CYP11B2, GABBR1, CNR1 | MEN1 402/4885LMNA 1273/4885THRB 2030/4885 |
| US-20210300872-A1 | SECOND GENERATION GRP94-SELECTIVE INHIBITORS | HSP90B1, HSP90AB2P, HSPE1 | MEN1 849/4885LMNA 3989/4885THRB 2726/4885 |
| US-20200190017-A1 | SECOND GENERATION GRP94-SELECTIVE INHIBITORS | HSP90B1, HSP90AB2P, HSPE1 | MEN1 853/4885LMNA 3960/4885THRB 2657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.